請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52857完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 蔡呈芳(Tsen-Fang Tsai) | |
| dc.contributor.author | Cheng-Yuan Li | en |
| dc.contributor.author | 李政源 | zh_TW |
| dc.date.accessioned | 2021-06-15T16:30:55Z | - |
| dc.date.available | 2016-09-25 | |
| dc.date.copyright | 2015-09-25 | |
| dc.date.issued | 2015 | |
| dc.date.submitted | 2015-08-13 | |
| dc.identifier.citation | National Health Insurance Research Database. The National Health Research Institutes, Taiwan.
(2007). Kanis JA. World Health Organization Scientific Group. Assessment of osteoporosis at the primary health care level.Technical Report., (World Health Organization Collaborating Centre for Metabolic Bone Diseases: University of Sheffield, UK). Abrahamsen, B., Brask-Lindemann, D., Rubin, K. H., and Schwarz, P. (2014). A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures. Bonekey Rep 3, 574. Alikhan, A., Felsten, L. M., Daly, M., and Petronic-Rosic, V. (2011). Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65, 473-91. Beheshti, A., Ghadami, H., Barikani, A., and Haj Manouchehri, F. (2014). Assessment of vitamin d plasma levels in patients with vitiligo vulgaris. Acta Med Iran 52, 601-6. Bleibler, F., Konnopka, A., Benzinger, P., Rapp, K., and Konig, H. H. (2013). The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany--a demographic simulation model. Osteoporos Int 24, 835-47. Burch, J., Rice, S., Yang, H., Neilson, A., Stirk, L., Francis, R., Holloway, P., Selby, P., and Craig, D. (2014). Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health technology assessment 18, 1-180. Cheng, C. L., Kao, Y. H., Lin, S. J., Lee, C. H., and Lai, M. L. (2011). Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20, 236-42. Feldmeyer, L., Shojaati, G., Spanaus, K. S., Navarini, A., Theler, B., Donghi, D., Urosevic-Maiwald, M., Glatz, M., Imhof, L., Barysch, M. J., et al. (2013). Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3. J Am Acad Dermatol 69, 530-6. Felsten, L. M., Alikhan, A., and Petronic-Rosic, V. (2011). Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol 65, 493-514. Grimes, P. E., Hamzavi, I., Lebwohl, M., Ortonne, J. P., and Lim, H. W. (2013). The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA dermatology 149, 68-73. Hallaji, Z., Ghiasi, M., Eisazadeh, A., and Damavandi, M. R. (2012). Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 28, 115-9. Hsiao Fy, Yang Cl, Huang Yt, and Huang Wf (2007). Using Taiwan national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal 15, 99-108. Hwang, J. S., Chan, D. C., Chen, J. F., Cheng, T. T., Wu, C. H., Soong, Y. K., Tsai, K. S., and Yang, R. S. (2014). Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary. J Bone Miner Metab 32, 10-6. Kanis, J. A. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4, 368-81. Khosla, S. (2013). Pathogenesis of age-related bone loss in humans. The journals of gerontology. Series A, Biological sciences and medical sciences 68, 1226-35. Kim, J. Y., Do, J. E., Ahn, K. J., Noh, S., Jee, H. J., and Oh, S. H. (2011). Detection of melanocyte autoantigens reacting with autoantibodies in vitiligo patients by proteomics. J Dermatol Sci 62, 202-4. Kleinpenning, M. M., Smits, T., Boezeman, J., Van De Kerkhof, P. C., Evers, A. W., and Gerritsen, M. J. (2009). Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol 161, 1351-6. Laberge, G., Mailloux, C. M., Gowan, K., Holland, P., Bennett, D. C., Fain, P. R., and Spritz, R. A. (2005). Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18, 300-5. Lin, Z. Z., Wang, J. J., Chung, C. R., Huang, P. C., Su, B. A., Cheng, K. C., Chio, C. C., and Chien, C. C. (2014). Epidemiology and mortality of hip fracture among patients on dialysis: Taiwan National Cohort Study. Bone 64, 235-9. Malerba, M., Damiani, G., Radaeli, A., Ragnoli, B., Olivini, A., and Calzavara-Pinton, P. G. (2015). Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol. Osmancevic, A., Landin-Wilhelmsen, K., Larko, O., Mellstrom, D., Wennberg, A. M., Hulthen, L., and Krogstad, A. L. (2007). UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed 23, 172-8. Osmancevic, A., Landin-Wilhelmsen, K., Larko, O., Mellstrom, D., Wennberg, A. M., Hulthen, L., and Krogstad, A. L. (2008). Risk factors for osteoporosis and bone status in postmenopausal women with psoriasis treated with UVB therapy. Acta Derm Venereol 88, 240-6. Paradisi, A., Tabolli, S., Didona, B., Sobrino, L., Russo, N., and Abeni, D. (2014). Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol 71, 1110-6. Premkumar, M., Sable, T., Dhanwal, D., and Dewan, R. (2013). Vitamin D homeostasis, bone mineral metabolism, and seasonal affective disorder during 1 year of Antarctic residence. Arch Osteoporos 8, 129. Riggs, B. L., Khosla, S., and Melton, L. J., 3rd (2002). Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23, 279-302. Sehrawat, M., Arora, T. C., Chauhan, A., Kar, H. K., Poonia, A., and Jairath, V. (2014). Correlation of Vitamin D Levels with Pigmentation in Vitiligo Patients Treated with NBUVB Therapy. ISRN Dermatol 2014, 493213. Silverberg, J. I., and Silverberg, N. B. (2013). Clinical features of vitiligo associated with comorbid autoimmune disease: a prospective survey. J Am Acad Dermatol 69, 824-6. Trautinger, F. (2011). Phototherapy of mycosis fungoides. Photodermatol Photoimmunol Photomed 27, 68-74. Ustun, I., Seraslan, G., Gokce, C., Motor, S., Can, Y., Ugur Inan, M., and Yilmaz, N. (2014). Investigation of vitamin d levels in patients with vitiligo vulgaris. Acta Dermatovenerol Croat 22, 110-3. Willson, T., Nelson, S. D., Newbold, J., Nelson, R. E., and Lafleur, J. (2015). The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol 7, 65-76. Yaghoobi, R., Omidian, M., and Bagherani, N. (2011). Vitiligo: a review of the published work. J Dermatol 38, 419-31. Yang, N. P., Deng, C. Y., Chou, Y. J., Chen, P. Q., Lin, C. H., Chou, P., and Chang, H. J. (2006). Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 75, 329-37. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52857 | - |
| dc.description.abstract | 背景: 照光治療可能可以增加骨質密度。然而白斑症病人所接受的照光治療是否能夠降低骨折的風險，截至目前為止仍然是未知的。
目的: 本研究希望能評估照光治療在大於四十歲的白斑症病人上，骨折風險的影響。 方法: 我們使用西元2000年至2010年的台灣全民健保資料庫的資料來進行研究。透過研究找出了共3863名在西元2003年至2009年間新診斷的大於四十歲的白斑症患者。我們進一步將研究的族群分類成三個族群世代來進行研究: 1) 頻繁照光組 – 平均每年至少接受照光治療超過12次; 2) 不頻繁照光組 – 平均每年接受照光治療介於1-12次之間; 3) 未照光組。接受研究的對象一直被追蹤直到發生第一次的髖關節或脊椎骨骨折、從健保資料中退保、或是追蹤終點 ( 西元2010年12月31日止)。資料被進一步使用COX 迴歸模式分析以及按照年齡以及性別分層分析。 結果: 頻繁的照光治療降低了40-64歲白斑症病人的骨折風險 (adjusted hazard ratio=0.18, p=0.009); 然而，進一步的按照性別分層分析顯示頻繁照光之骨折風險防護的效果僅在女性患者中顯現 (adjusted hazard ratio=0.19, p=0.014)。 結論: 本研究提供了第一個證據: 頻繁的照光治療能在中年的白斑症女性患者上，降低骨折的發生風險。 | zh_TW |
| dc.description.abstract | Background: Phototherapy might increase bone mineral density. However, it is unknown whether phototherapy can reduce the risk of fractures in patients with vitiligo.
Objectives: To investigate the effect of phototherapy on fracture risk in vitiligo patients aged 40 or older. Methods: This population-based cohort study used the 2000–2010 Taiwan National Health Insurance Research Database (NHIRD) to identify 3,863 patients newly diagnosed with vitiligo between 2003 and 2009 at age ≥40 years. Study subjects were classified into three cohorts: 1) frequent phototherapy; 2) infrequent phototherapy; and 3) no phototherapy. Patients were followed until the first hip or vertebral fracture or 31 December 2010. Data were analysed using Cox regression models and also stratified by age and gender. Results: Frequent phototherapy decreased the fracture risk in patients aged 40–64 years (adjusted hazard ratio=0.18, p=0.009); however, stratification by gender confirmed the fracture prevention effect of frequent phototherapy in female patients only (adjusted hazard ratio=0.19, p=0.014). Limitations: Some potential confounding variables for fractures were not available in the Taiwan NHIRD. Conclusions: This study provides the first evidence that frequent phototherapy can reduce the risk of fractures among middle-aged women with vitiligo. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T16:30:55Z (GMT). No. of bitstreams: 1 ntu-104-P02421004-1.pdf: 874946 bytes, checksum: a859b09ed01015ea5bbf41df295bc06a (MD5) Previous issue date: 2015 | en |
| dc.description.tableofcontents | 口試委員會審定書………………………………………………………… i
致謝…………………………………………………………………………………… ii 中文摘要………………………………………………………………………… iii 英文摘要…………………………………………………………………………… iv 碩士論文內容 Introduction………………………………………………………………… 1 Materials and methods………………………………………… 3 Results……………………………………………………………………………… 7 Discussion……………………………………………………………………… 9 Acknowledgements……………………………………………………… 14 References……………………………………………………………………… 15 Tables………………………………………………………………………………… 20 Figures……………………………………………………………………………… 22 | |
| dc.language.iso | en | |
| dc.subject | 照光治療 | zh_TW |
| dc.subject | 骨折風險 | zh_TW |
| dc.subject | 白斑 | zh_TW |
| dc.subject | osteoporosis | en |
| dc.subject | fracture | en |
| dc.subject | phototherapy | en |
| dc.subject | vitiligo | en |
| dc.subject | gender | en |
| dc.subject | National Health Insurance Research Database | en |
| dc.title | 接受照光治療的白斑症病人，骨折之風險評估 | zh_TW |
| dc.title | Risk of fractures in vitiligo patients treated with phototherapy – a retrospective population-based cohort | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 103-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李定達(Ding-Dar Lee),陳祈玲(Chi-Ling Chen) | |
| dc.subject.keyword | 白斑,照光治療,骨折風險, | zh_TW |
| dc.subject.keyword | osteoporosis,fracture,phototherapy,vitiligo,gender,National Health Insurance Research Database, | en |
| dc.relation.page | 22 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2015-08-13 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
| 顯示於系所單位： | 臨床醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-104-1.pdf 未授權公開取用 | 854.44 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。